They could lose the case against Sheey. My own inclination is his option contract would (or should) be protected against dilution. Whether he gets the opportunity cost is doubtful. Courts tend not to listen to these.
Revenue could be lost, leading to another downgrade. In this game, it costs money to stand still. Competition is nipping at their heels.
I don't like this SAS model. It means competitors can take any thin slice of business they want. The full licence is far better because it ties for the duration.
Nuix catalysts going forward, page-26
-
- There are more pages in this discussion • 61 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NXL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.49 |
Change
-0.090(2.51%) |
Mkt cap ! $1.129B | |||
| Open | High | Low | Value | Volume |
| $3.56 | $3.61 | $3.43 | $2.593M | 743.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $3.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.50 | 2633 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| NXL (ASX) Chart |